Showing results (411-420 of 430) with videos related to
Sort By:
Pageof 43
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 23, 2022
Transcranial magnetic stimulation of the brain: What is stimulated? - A consensus and critical position paperHartwig R Siebner, Klaus Funke, Aman S Aberra, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 1, 2026
Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines (2017-2025: An update) - endorsed by the European Society for Brain Stimulation (ESBS) and by the International Federation for Clinical Neurophysiology (IFCN)Andrea Antal, Jovana Bjekić, Ana Ganho-Ávila, et al.Arxiv|October 3, 2025
Roadmap towards Personalized Approaches and Safety Considerations in Non-Ionizing Radiation: From Dosimetry to Therapeutic and Diagnostic ApplicationsIlkka Laakso, Margarethus Marius Paulides, Sachiko Kodera, et al.Physics in Medicine and Biology|November 21, 2025
Roadmap towards personalized approaches and safety considerations in non-ionizing radiation: from dosimetry to therapeutic and diagnostic applicationsIlkka Laakso, Maarten M Paulides, Sachiko Kodera, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 7, 2021
Training in the practice of noninvasive brain stimulation: Recommendations from an IFCN committeePeter J Fried, Emiliano Santarnecchi, Andrea Antal, et al.Nature Genetics|July 29, 2008
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndromeBarbara Schormair, David Kemlink, Darina Roeske, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 6, 2020
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)Jean-Pascal Lefaucheur, André Aleman, Chris Baeken, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 2, 2017
Biomarkers predict outcome in Charcot-Marie-Tooth disease 1ARobert Fledrich, Manoj Mannil, Andreas Leha, et al.Clinical Neurophysiology Practice|June 23, 2022
Non-invasive brain stimulation and neuroenhancementAndrea Antal, Bruce Luber, Anna-Katharine Brem, et al.Neuromuscular Disorders : NMD|August 3, 2014
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patientsManoj Mannil, Alessandra Solari, Andreas Leha, et al.Pageof 43